PL3102187T3 - Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu - Google Patents

Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu

Info

Publication number
PL3102187T3
PL3102187T3 PL15702266T PL15702266T PL3102187T3 PL 3102187 T3 PL3102187 T3 PL 3102187T3 PL 15702266 T PL15702266 T PL 15702266T PL 15702266 T PL15702266 T PL 15702266T PL 3102187 T3 PL3102187 T3 PL 3102187T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
compositions containing
immediate release
release tablets
stable pharmaceutical
Prior art date
Application number
PL15702266T
Other languages
English (en)
Inventor
Sergio Arroyo Hidalgo
Mireia Pladevall Rosés
Original Assignee
Galenicum Health S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50033373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3102187(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galenicum Health S.L. filed Critical Galenicum Health S.L.
Publication of PL3102187T3 publication Critical patent/PL3102187T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15702266T 2014-02-03 2015-02-03 Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu PL3102187T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14153671 2014-02-03
EP15702266.6A EP3102187B1 (en) 2014-02-03 2015-02-03 Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
PCT/EP2015/052121 WO2015114152A1 (en) 2014-02-03 2015-02-03 Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets

Publications (1)

Publication Number Publication Date
PL3102187T3 true PL3102187T3 (pl) 2020-10-19

Family

ID=50033373

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15702266T PL3102187T3 (pl) 2014-02-03 2015-02-03 Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu

Country Status (9)

Country Link
EP (1) EP3102187B1 (pl)
CY (1) CY1123022T1 (pl)
ES (1) ES2792506T3 (pl)
HU (1) HUE049298T2 (pl)
PL (1) PL3102187T3 (pl)
PT (1) PT3102187T (pl)
RS (1) RS60393B1 (pl)
SI (1) SI3102187T1 (pl)
WO (1) WO2015114152A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3102187T1 (sl) 2014-02-03 2020-08-31 Galenicum Health S.L. Stabilne farmacevtske sestave, ki vsebujejo sitagliptin v obliki tablet s takojšnjim sproščanjem
EP4045048A4 (en) * 2019-10-14 2023-05-24 Santa Farma Ilaç Sanayi A.S. ORAL FORMULATIONS WITH SITAGLIPTIN HCI MONOHYDRATE WITH IMPROVED PHARMACEUTICAL PROPERTIES
JP7423264B2 (ja) * 2019-10-17 2024-01-29 日本ジェネリック株式会社 シタグリプチン含有錠剤
GR1010089B (el) 2020-09-15 2021-09-27 Φαρματεν Α.Β.Ε.Ε. Στερεη φαρμακοτεχνικη μορφη περιεχουσα σιταγλιπτινη και μεθοδος παρασκευης αυτης
WO2022074664A1 (en) * 2020-10-05 2022-04-14 V-Ensure Pharma Technologies Private Limited An immediate release composition of sitagliptin hydrochloride
CN113143929B (zh) * 2021-04-15 2023-04-07 浙江诺得药业有限公司 一种西格列汀复方制剂的制备方法
JP2025076633A (ja) * 2023-11-02 2025-05-16 沢井製薬株式会社 シタグリプチン製剤及びその保管方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3766885D1 (en) 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
JO2625B1 (en) 2003-06-24 2011-11-01 ميرك شارب اند دوم كوربوريشن Phosphoric acid salts of dipeptidyl betidase inhibitor 4
US20080227786A1 (en) * 2004-01-16 2008-09-18 Ferlita Russell R Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
CA2633167A1 (en) 2005-12-16 2007-07-12 Merck & Co., Inc. Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
WO2009084024A2 (en) 2007-11-02 2009-07-09 Glenmark Generics Limited A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
EP2915814A3 (en) 2008-07-03 2015-10-07 ratiopharm GmbH Crystalline salts of sitagliptin
EP2470542A4 (en) 2009-08-28 2013-04-24 Reddys Lab Ltd Dr PREPARATION OF SITAGLIPTIN AND SALTS THEREOF
US20130158265A1 (en) 2010-08-27 2013-06-20 Dhananjay Govind Sathe Sitagliptin, salts and polymorphs thereof
EP2691083B1 (en) * 2011-03-29 2017-08-02 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition of sitagliptin
WO2012166420A1 (en) 2011-05-27 2012-12-06 Merck Sharp & Dohme Corp. Phosphoric acid salts of sitagliptin
EP2578208B1 (en) 2011-10-06 2014-05-21 Sanovel Ilac Sanayi ve Ticaret A.S. DPP-IV inhibitor solid dosage formulations
ES2421956B1 (es) 2012-03-02 2014-09-29 Moehs Ibérica S.L. Nueva forma cristalina de sulfato de sitagliptina
SI3102187T1 (sl) 2014-02-03 2020-08-31 Galenicum Health S.L. Stabilne farmacevtske sestave, ki vsebujejo sitagliptin v obliki tablet s takojšnjim sproščanjem

Also Published As

Publication number Publication date
EP3102187A1 (en) 2016-12-14
WO2015114152A1 (en) 2015-08-06
SI3102187T1 (sl) 2020-08-31
ES2792506T3 (es) 2020-11-11
RS60393B1 (sr) 2020-07-31
HUE049298T2 (hu) 2020-09-28
CY1123022T1 (el) 2021-10-29
EP3102187B1 (en) 2020-03-25
PT3102187T (pt) 2020-06-17

Similar Documents

Publication Publication Date Title
IL252477A0 (en) 2-aminopyrimidine compound, pharmaceutical structure and its use
ZA201605300B (en) Pharmaceutical compositions comprising azd9291
GB201409471D0 (en) Pharmaceutical composition
IL249803B (en) History of azafenil and pharmaceutical preparations containing them
HUE052386T2 (hu) Hatóanyagok felszabadítására szolgáló szemcsék
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
SI3102187T1 (sl) Stabilne farmacevtske sestave, ki vsebujejo sitagliptin v obliki tablet s takojšnjim sproščanjem
GB201409488D0 (en) Pharmaceutical composition
SI3135275T1 (sl) Farmacevtski pripravek, ki je sposoben vključitve lenalidomida v različnih kristaliničnih modifikacijah
GB201409485D0 (en) Pharmaceutical composition
PL3278801T3 (pl) Kompozycja farmaceutyczna zawierająca mirabegron
PT3200772T (pt) Composições farmacêuticas compreendendo alpelisib
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
SMT202100074T1 (it) Uso di una composizione contenente benzoato in disturbi del ciclo dell'urea e disturbi neurodegenerativi
IL266825A (en) Pharmaceutical formulation containing tadalafil
PT3089740T (pt) Composição farmacêutica
SG11201608123VA (en) Pharmaceutical composition for external use
ZA201500995B (en) Low dose pharmaceutical composition
PL2915526T3 (pl) Mieszaniny farmaceutyczne zawierające anagrelid
SG10201504332VA (en) Pharmaceutical Composition
SG11201608124XA (en) Pharmaceutical composition for external use
SG11201608122PA (en) Pharmaceutical composition for external use